TempraMed Technologies Ltd. (TempraMedT) Aktie

TempraMed Technologies Ltd., a medical device technology company, develops patent-protected technology designed to serve a broad range of medical and consumer products. Its primary focus is storage and management of injectable for temperature-sensitive medications. The company provides VIVI Cap, an insulin insulation and travel case; VIVI Cap Smart, a connected insulin storage and protection; VIVI Med, a temperature medication; and VIVI Epi, a Storage and Protection for EpiPen. The company was incorporated in 2023 and is based in Burnaby, Canada.